Botanix Pharmaceuticals Ltd

BOT

Company Profile

  • Business description

    Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

  • Contact

    41 - 47 Colin Street
    Suite 3
    West PerthWA6005
    AUS

    T: +61 865552945

    https://www.botanixpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,808.8017.90-0.20%
CAC 407,902.2523.790.30%
DAX 4024,456.8192.75-0.38%
Dow JONES (US)44,650.64192.340.43%
FTSE 1008,975.66108.641.23%
HKSE24,400.68372.311.55%
NASDAQ20,630.6619.330.09%
Nikkei 22539,602.1544.21-0.11%
NZX 50 Index12,690.0070.20-0.55%
S&P 5006,280.4617.200.27%
S&P/ASX 2008,568.8020.40-0.24%
SSE Composite Index3,534.6925.010.71%

Market Movers